Genetic immunization with in vivo dendritic cell-targeting liposomal DNA vaccine carrier induces long-lasting antitumor immune response

Molecular Therapy

Volumn 24, Issue 2, 2016, Pages 385-397

  Garu, Arup ^a   Moku, Gopikrishna ^a,b   Gulla, Suresh Kumar ^a,b   Chaudhuri, Arabinda ^a,b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; DNA VACCINE; GREEN FLUORESCENT PROTEIN; LIPID; LIPOSOME; MANNOSE RECEPTOR; MELANOMA ANTIGEN; CANCER VACCINE; GLYCOPROTEIN P 15095;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA IMMUNIZATION; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; GENETIC IMMUNIZATION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMID; TUMOR REGRESSION; ACTIVE IMMUNOTHERAPY; ANIMAL; BIOMIMETICS; GENETICS; IMMUNOLOGY; NEOPLASMS;

ANIMALS; ANTIGENS, CD11C; BIOMIMETICS; CANCER VACCINES; DENDRITIC CELLS; FEMALE; IMMUNOTHERAPY, ACTIVE; LIPOSOMES; MICE; NEOPLASMS; VACCINES, DNA;

EID: 84959462314     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.215     Document Type: Article

References (42)

1. Banchereau, J and Steinman, RM (1998). Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Banchereau, J, Briere, F, Caux, C, Davoust, J, Lebecque, S, Liu, YJ, et al. (2000). Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
3. Reis, CS (2001). Dendritic cells as sensors of infection. Immunity 14: 495-498.
4. Hsu, FJ, Benike, C, Fagnoni, F, Liles, TM, Czerwinski, D, Taidi, B, et al. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2: 52-58.
5. Nestle, FO, Alijagic, S, Gilliet, M, Sun, Y, Grabbe, S, Dummer, R, et al. (1998). Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 4: 328-332.
6. Irvine, AS, Trinder, PK, Laughton, DL, Ketteringham, H, McDermott, RH, Reid, SC, et al. (2000). Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nat Biotechnol 18: 1273-1278.
7. Lu, W, Arraes, LC, Ferreira, WT and Andrieu, JM (2004). Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med 10: 1359-1365.
8. Srinivas, R, Karmali, PP, Pramanik, D, Garu, A, Mahidhar, YV, Majeti, BK, et al. (2010). Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization. J Med Chem 53: 1387-1391.
9. Srinivas, R, Garu, A, Moku, G, Agawane, SB and Chaudhuri, A (2012). A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannosemimicking head-groups. Biomaterials 33: 6220-6229.
10. Paulis, LE, Mandal, S, Kreutz, M and Figdor, CG (2013). Dendritic cell-based nanovaccines for cancer immunotherapy. Curr Opin Immunol 25: 389-395.
11. Dewitte, H, Verbeke, R, Breckpot, K, De Smedt, SC and Lentacker, I (2014). Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment. Nano Today 9: 743-758.
12. Daftarian, P, Kaifer, AE, Li, W, Blomberg, BB, Frasca, D, Roth, F, et al. (2011). Peptideconjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigenpresenting cells. Cancer Res 71: 7452-7462.
13. Tian, S, Liu, Z, Donahue, C, Falo, LD Jr and You, Z (2012). Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity. Mol Ther 20: 432-442.
14. Raghuwanshi, D, Mishra, V, Das, D, Kaur, K and Suresh, MR (2012). Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein. Mol Pharm 9: 946-956.
15. Cao, J, Jin, Y, Li, W, Zhang, B, He, Y, Liu, H, et al. (2013). DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice. BMC Immunol 14: 39.
16. Raviv, L, Jaron-Mendelson, M and David, A (2015). Mannosylated polyion complexes for in vivo gene delivery into CD11c(+) dendritic cells. Mol Pharm 12: 453-462.
17. Inaba, K, Inaba, M, Romani, N, Aya, H, Deguchi, M, Ikehara, S, et al. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
18. Nchinda, G, Kuroiwa, J, Oks, M, Trumpfheller, C, Park, CG, Huang, Y, et al. (2008). The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest 118: 1427-1436.
19. Zhai, Y, Yang, JC, Spiess, P, Nishimura, MI, Overwijk, WW, Roberts, B, et al. (1997). Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100. J Immunother 20: 15-25.
20. Kutzler, MA and Weiner, DB (2008). DNA vaccines: ready for prime time? Nat Rev Genet 9: 776-788.
21. Liu, MA (2011). DNA vaccines: an historical perspective and view to the future. Immunol Rev 239: 62-84.
22. Mennuni, C, Calvaruso, F, Facciabene, A, Aurisicchio, L, Storto, M, Scarselli, E, et al. (2005). Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA. Int J Cancer 117: 444-455.
23. Rice, J, Dossett, ML, Ohlén, C, Buchan, SL, Kendall, TJ, Dunn, SN, et al. (2008). DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire. Eur J Immunol 38: 2118-2130.
24. Qian, J, Zheng, Y, Zheng, C, Wang, L, Qin, H, Hong, S, et al. (2012). Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma. Blood 119: 161-169.
25. Quaak, SG, Haanen, JB, Beijnen, JH, Nuijen, B (2010). Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation AAPS Pharm Sci Tech 11: 344-350.
26. Dudley, ME, Wunderlich, JR, Robbins, PF, Yang, JC, Hwu, P, Schwartzentruber, DJ, et al. (2002). Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298: 850-854.
27. Ahmed, R and Akondy, RS (2011). Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines. Immunol Cell Biol 89: 340-345.
28. Melief, CJ (2008). Cancer immunotherapy by dendritic cells. Immunity 29: 372-383.
29. Klebanoff, CA, Acquavella, N, Yu, Z and Restifo, NP (2011). Therapeutic cancer vaccines: are we there yet? Immunol Rev 239: 27-44.
30. Gilboa, E (2007). DC-based cancer vaccines. J Clin Invest 117: 1195-1203.
31. Steinman, RM (2008). Dendritic cells in vivo: a key target for a new vaccine science. Immunity 29: 319-324.
32. Palucka, K, Ueno, H and Banchereau, J (2011). Recent developments in cancer vaccines. J Immunol 186: 1325-1331.
33. Sancho, D, Mourão-Sá, D, Joffre, OP, Schulz, O, Rogers, NC, Pennington, DJ, et al. (2008). Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-Type lectin. J Clin Invest 118: 2098-2110.
34. Caminschi, I, Lahoud, MH and Shortman, K (2009). Enhancing immune responses by targeting antigen to DC. Eur J Immunol 39: 931-938.
35. Tian, S, Liu, Z, Donahue, C, Noh, HS, Falo, Jr. L.D. and You, Z (2009). Transcriptional IL-15-Directed in vivo DC targeting DNA vaccine. Gene Ther 16: 1260-1270.
36. Sen, J and Chaudhuri, A (2005). Design, syntheses and transfection biology of novel non-cholesterol-based guanidinylated cationic lipids. J Med Chem 48: 812-820.
37. Vigneron, JP, Oudrhiri, N, Fauquet, M, Vergely, L, Bradley, JC, Basseville, M, et al. (1996). Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci USA 93: 9682-9686.
38. Kaech, SM and Ahmed, R (2003). Immunology. CD8 T cells remember with a little help. Science 300: 263-265.
39. Whitmore, M, Li, S and Huang, L (1999). LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 6: 1867-1875.
40. McKeever, U, Barman, S, Hao, T, Chambers, P, Song, S, Lunsford, L, et al. (2002). Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles. Vaccine 20: 1524-1531.
41. McKinney, DM, Skvoretz, R, Qin, M, Ishioka, G and Sette, A (2000). Characterization of an in situ IFN-gamma ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization. J Immunol Methods 237: 105-117.
42. Mockey, M, Bourseau, E, Chandrashekhar, V, Chaudhuri, A, Lafosse, S, Le Cam, E, et al. (2007). mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes. Cancer Gene Ther 14: 802-814.